Schizophrenia & Psychotic Disorders

As many as one-quarter of suicide attempts are associated with psychotic experiences, according to a systematic review and meta-analysis published online in JAMA Psychiatry.

Articles

Frequent cannabis use and psychotic-like experiences (PLEs) seem to be associated with person-specific vulnerabilities, not just genetic factors, researchers say.

ORLANDO, Fla.—Brexpiprazole demonstrated “robust efficacy” in the treatment of patients with schizophrenia who have severe psychotic symptoms, researchers reported at Psych Congress 2018.

ORLANDO, Fla—A novel agent for the treatment of schizophrenia is producing promising results in efficacy and safety trials. Researchers presented an overview of late-stage studies of the drug at Psych Congress 2018.

Vast individual differences in brain structure make the concept of “the average patient with schizophrenia” practically meaningless, suggests a study published online in JAMA Psychiatry.

New guidelines from the European Psychiatric Association promote exercise as a core part of treatment for severe mental illnesses, including major depressive disorder and schizophrenia.

Pages

Blogs

Generic medications may potentially offer significant savings for patients. However, it's important to understand how these medications are similar and different from brand-name medications.

Question:

"Is schizophrenia really a valid diagnostic entity?"

Question:

"In view of the specific structural and neuroendocrine changes now known to occur in schizophrenia, is there any role for therapy—such as cognitive therapy or cognitive enhancement therapy?"

Pages

Posters

Rikinkumar Patel, MD, MPH; Mandeep Kaur, MD; Ahmed Elmaadawi, MD; Zeeshan Mansuri, MD, MPH; Kaushal Shah, MBBS, MPH; Suhayl Nasr, MD
Jason Shafrin, PhD; Katalin Bognar, PhD; Katie Everson, MS; Michelle Brauer, BS; Darius Lakdawalla, PhD; Felicia Forma, BSc
Abigail Nash, MD, PhD; Ibrahim Turkoz, PhD; Adam Savitz, MD, PhD; Maju Mathews, MD; Edward Kim, MD, MBA
Karen Anderson, MD; Mat Davis, PhD; Stewart Factor, DO; Robert Hauser, MD, MBA; Lars Jarskog, MD; Joohi Jimenez-Shahed, MD; Rajeev Kumar, MD, FRCPC; Stanislaw Ochudlo, MD, PhD; William Ondo, MD; Hubert Fernandez, MD

Pages

Video

Schizophrenia long-acting injectables

This video is a component of an accredited CME session presented at Elevate by Psych Congress 2017.

The educational activity is supported by educational grants from Alkermes, Inc. and Otsuka America Pharmaceuticals, Inc.

Long-acting injectables schizophrenia

This video is a component of an accredited CME session presented at Elevate by Psych Congress 2017.

The educational activity is supported by educational grants from Alkermes, Inc. and Otsuka America Pharmaceuticals, Inc.

Joseph P. McEvoy, MD, discusses how cannabis affects the risk of schizophrenia and the course of the disease. Dr. McEvoy is Professor of Psychiatry and Health Behavior and the I. Clark Case Chair in Psychotic Disorders at the Medical College of Georgia.

Pages

Audio

Why do so many antipsychotic medications induce symptoms, signs, and physiologic changes that are already present to a lesser degree in the disease states that they are intended to treat?

Pages